Secretin Receptors on Neuroblastoma Cell Membranes: Characterization of 125I‐Labeled Secretin Binding and Association with Adenylate Cyclase

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Neurochemistry

• Publication date

  1984-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.1984.tb12723.xPMID 6321661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini.

  1983cited by this paper
• Secretin: specific binding to rat brain membranes

  1983cited by this paper
• Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion.

  1982cited by this paper
• Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites.

  1982cited by this paper
• Modulation of sodium-sensitive GTPase by partial opiate agonists. An explanation for the dual requirement for Na+ and GTP in inhibitory regulation of adenylate cyclase.

  1982cited by this paper
• Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.

  1981cited by this paper
• Purification and properties of the regulatory component (G/F) of adenylate cyclase.

  1981cited by this paper
• Identification, characterization, and distribution of secretin immunoreactivity in rat and pig brain.

  1981cited by this paper
• Actions of a newly isolated intestinal peptide PHI on pancreatic acini.

  1981cited by this paper
• Effects of proteinase inhibitors on adenylate cyclase.

  1980cited by this paper
• Adenylate cyclase: The role of magnesium and other divalent cations

  1980cited by this paper
• The role of hormone receptors and GTP-regulatory proteins in membrane transduction

  1980cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Secretin and VIP-stimulated adenylate cyclase from rat heart

  1980cited by this paper
• Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI)

  1980cited by this paper
• Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells.

  1980cited by this paper
• Distribution of vasoactive intestinal polypeptide in the rat and mouse brain.

  1979cited by this paper
• THE INFLUENCE OF SECRETIN, GLUCAGON AND OTHER PEPTIDES, OF AMINO ACIDS, PROSTAGLANDIN ENDOPEROXIDE ANALOGUES AND DIAZEPAM ON THE LEVEL OF ADENOSINE 3′,5′‐CYCLIC MONOPHOSPHATE IN NEUROBLASTOMA GLIOMA HYBRID CELLS

  1979influential reference
• Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

  1979cited by this paper
• Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brain.

  1979cited by this paper
• Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain.

  1978cited by this paper
• Specific binding of vasoactive intestinal peptide to brain membranes from the guinea pig.

  1978cited by this paper
• Relationship between the beta-adrenergic receptor and adenylate cyclase.

  1977cited by this paper
• Characterization of VIP‐sensitive adenylate cyclase in guinea pig brain

  1977cited by this paper
• Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Membrane receptors for hormones and neurotransmitters

  1976cited by this paper
• Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate.

  1976cited by this paper
• Diagnostic uses of the Hill (Logit and Nernst) plots.

  1975cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper
• An improved protein binding assay for cyclic AMP.

  1974cited by this paper
• A protein binding assay for adenosine 3':5'-cyclic monophosphate.

  1970cited by this paper

• Secretin: a hormone for HCO3− homeostasis

  2024cites this paper
• Secretin Regulates Excitatory GABAergic Neurotransmission to GnRH Neurons via Retrograde NO Signaling Pathway in Mice

  2019cites this paper
• Distribution and Functional Implication of Secretin in Multiple Brain Regions

  2018cites this paper
• Postpyloric Gastrointestinal Peptides

  2012cites this paper
• Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis

  2011cites this paper
• Secretin: Should we revisit its metabolic outcomes?

  2010cites this paper
• Role of type 2 cannabinoid receptor in bone metabolism

  2009cites this paper
• CHAPTER 5 – Postpyloric Gastrointestinal Peptides

  2006cites this paper
• Signaling mechanisms of secretin receptor.

  2006cites this paper
• Embryonal central neuroepithelial tumors: Current concepts and future challenges

  2004cites this paper
• In vitro autoradiographic localization of (125)i-secretin receptor binding sites in rat brain.

  2002cites this paper
• Zinc Inhibition of cAMP Signaling*

  2002cites this paper
• Nitric oxide and the other cyclic nucleotide.

  2002cites this paper
• Adenylyl cyclase types I and VI but not II and V are selectively inhibited by nitric oxide.

  2002cites this paper
• Regulation of adenylate cyclase by galanin, neuropeptide Y, secretin and vasoactive intestinal polypeptide in rat frontal cortex, hippocampus and hypothalamus.

  1995cites this paper
• Secretin stimulates bile ductular secretory activity through the cAMP system.

  1992cites this paper
• Assays for Secretin Receptors: Comparison between Neuroblastoma Cells and Exocrine Pancreas

  1991cites this paper
• Molecular cloning and expression of a cDNA encoding the secretin receptor.

  1991cites this paper
• Secretin receptors in the neuroglioma hybrid cell line NG108-15. Characterization and regulation of their expression.

  1990cites this paper
• Characterization of cell surface antigens on the adrenergic neuroblastoma clone A2(1).

  1988cites this paper
• Immunohistochemical analysis of the ontogeny of peptide histidine isoleucine (PHI)-immunoreactive neurons in the pre- and postnatal rat brain.

  1988cites this paper
• The Regulation of Vasoactive Intestinal Peptide Synthesis in Neuroblastoma and Chromaffin Cells a

  1988cites this paper
• Analysis of receptor-coupled events in neuropeptide action using clonal cell lines.

  1987cites this paper
• Thyroid effects on adenosine 3',5'-monophosphate levels and adenylate cyclase in cultured neuroblastoma cells.

  1987cites this paper
• Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells

  1987cites this paper
• Secretin Stimulates Cyclic AMP Formation in the Rat Brain

  1986cites this paper
• Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.

  1986cites this paper
• Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.

  1985cites this paper
• The Subcellular Distribution of Peptide Histidine Isoleucine Amide‐27‐Like Peptides in Rat Brain and Their Release from Rat Cerebral Cortical Slices In Vitro

  1985cites this paper
• Synthesis and release of vasoactive intestinal polypeptide (VIP) by mouse neuroblastoma cells: modulation by cyclic nucleotides and ascorbic acid.

  1985cites this paper
• The distribution and chromatographic characterization of PHI (peptide histidine isoleucine amide)-27-like peptides in rat and porcine brain

  1984cites this paper
• Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds.

  1984cites this paper
• Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.

  1984cites this paper